Literature DB >> 12367601

Presynaptic factors in the regulation of DSI expression in hippocampus.

Namita Varma1, Darrin Brager, Wade Morishita, Robert A Lenz, Barry London, Bradley Alger.   

Abstract

We studied the mechanisms by which GABA release is reduced in the retrograde signaling process called depolarization-induced suppression of inhibition (DSI). DSI is mediated by endocannabinoids in acute and cultured organotypic hippocampal slices. We examined a variety of K(+) channel antagonists to determine the nature of the K(+) channel that, when blocked, reduces DSI. Among 4-AP, TEA, dendrotoxin, Cs, margatoxin, and charybdotoxin, only 4-AP was highly effective in blocking DSI, suggesting that a K(+) channel composed in part of K(V1.4,) K(V1.5) or K(V1.7) subunits can readily regulate DSI. The inhibition of DSI by 4-AP is largely overcome by reducing [Ca(2+)](o), however, suggesting that DSI expression can be prevented by saturation of the release process when a K(V1.X) channel is inhibited. DSI of agatoxin- and TTX-insensitive mIPSCs was unaffected by 4-AP, but was largely occluded by omega-conotoxin GVIA, indicating that block of presynaptic N-type Ca(2+) channels is probably a major mechanism of DSI expression. Significant DSI of mIPSCs remained in omega-conotoxin, hence we infer that block of N-channels does not fully explain hippocampal DSI expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12367601     DOI: 10.1016/s0028-3908(02)00168-5

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  15 in total

1.  Endocannabinoids and their implications for epilepsy.

Authors:  Bradley E Alger
Journal:  Epilepsy Curr       Date:  2004 Sep-Oct       Impact factor: 7.500

2.  Presynaptic, activity-dependent modulation of cannabinoid type 1 receptor-mediated inhibition of GABA release.

Authors:  Csaba Földy; Axel Neu; Mathew V Jones; Ivan Soltesz
Journal:  J Neurosci       Date:  2006-02-01       Impact factor: 6.167

3.  Miniature synaptic events elicited by presynaptic Ca2+ rise are selectively suppressed by cannabinoid receptor activation in cerebellar Purkinje cells.

Authors:  Miwako Yamasaki; Kouichi Hashimoto; Masanobu Kano
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

4.  Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity.

Authors:  Robert E Hampson; Frances Miller; Guillermo Palchik; Sam A Deadwyler
Journal:  Neuropharmacology       Date:  2011-02-01       Impact factor: 5.250

5.  Synaptic activation of kainate receptors gates presynaptic CB(1) signaling at GABAergic synapses.

Authors:  Joana Lourenço; Astrid Cannich; Mario Carta; Françoise Coussen; Christophe Mulle; Giovanni Marsicano
Journal:  Nat Neurosci       Date:  2010-01-17       Impact factor: 24.884

6.  Regulation of excitability and plasticity by endocannabinoids and PKA in developing hippocampus.

Authors:  Hiroki Yasuda; Yan Huang; Tadaharu Tsumoto
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

Review 7.  Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE).

Authors:  Marco A Diana; Alain Marty
Journal:  Br J Pharmacol       Date:  2004-04-20       Impact factor: 8.739

Review 8.  Endocannabinoid signaling and long-term synaptic plasticity.

Authors:  Boris D Heifets; Pablo E Castillo
Journal:  Annu Rev Physiol       Date:  2009       Impact factor: 19.318

9.  Distinctions among GABAA and GABAB responses revealed by calcium channel antagonists, cannabinoids, opioids, and synaptic plasticity in rat hippocampus.

Authors:  Carlos A Lafourcade; Bradley E Alger
Journal:  Psychopharmacology (Berl)       Date:  2007-12-21       Impact factor: 4.530

Review 10.  Type-1 metabotropic glutamate receptor in cerebellar Purkinje cells: a key molecule responsible for long-term depression, endocannabinoid signalling and synapse elimination.

Authors:  Masanobu Kano; Kouichi Hashimoto; Toshihide Tabata
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-06-27       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.